Skip to main content
Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.2898
+0.0208 (7.73%)
At close: Sep 26, 2025, 4:00 PM EDT
0.2895
-0.0003 (-0.10%)
After-hours: Sep 26, 2025, 7:58 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy
19.63M
Log In
Log In
Log In
Log In
Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy Growth
31.59%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
19.63M
Log In
Log In
Log In
Log In
United States Growth
31.59%
Log In
Log In
Log In
Log In